ConductScience.org, home

Paper36792575

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.

Ivanochko D and 24 others. Immunity, 2023. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230. Papers, record 36792575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36792575

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
PubMed
Journal
Immunity
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
2.51
iCite
Revised in PubMed
2026-05-26
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ivanochko DDanton
2Fabra-García AAmanda
3Teelen KKarina
4van de Vegte-Bolmer MMarga
5van Gemert GJGeert-Jan
6Newton JJocelyn
7Semesi AAnthony
8de Bruijni MMarloes
9Bolscher JJudith
10Ramjith JJordache
11Szabat MMarta
12Vogt SStefanie
13Kraft LLucas
14Duncan SSherie
15Lee SMShwu-Maan
16Kamya MRMoses R
17Feeney MEMargaret E
18Jagannathan PPrasanna
19Greenhouse BBryan
20Sauerwein RWRobert W

Source PubMed

See all 25 authorsDownload CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Malaria, FalciparumMajor topic
Malaria VaccinesMajor topic
Humans
Animals
Plasmodium falciparum
Epitopes
Protozoan Proteins
Antigens, Protozoan
Antibodies, Monoclonal
Antibodies, Protozoan

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K24 AI144048NIAID NIH HHSUnited StatesK24AI144048PubMedNIH RePORTER
S10 OD012289NIH HHSUnited StatesS10OD012289PubMed and NIHNIH RePORTER
K24 AI113002NIAID NIH HHSUnited StatesK24AI113002PubMed and NIHNIH RePORTER
U19 AI089674NIAID NIH HHSUnited StatesU19AI089674PubMed and NIHNIH RePORTER
R01 AI093615NIAID NIH HHSUnited StatesR01AI093615PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in36792569X marks the shot against malaria.https://conductscience.org/library/papers/36792569

Source PubMed

Download CSV of comments and corrections

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131551421Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25.Nat Commun2019https://conductscience.org/library/papers/31551421PubMed
234725428Persistent Plasmodium falciparum infections enhance transmission-reducing immunity development.Sci Rep2021https://conductscience.org/library/papers/34725428PubMed
333561016Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.J Clin Invest2021https://conductscience.org/library/papers/33561016PubMed
420124702PHENIX: a comprehensive Python-based system for macromolecular structure solution.Acta Crystallogr D Biol Crystallogr2010https://conductscience.org/library/papers/20124702PubMed
52865324Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.J Exp Med1985https://conductscience.org/library/papers/2865324PubMed
619461840Phaser crystallographic software.J Appl Crystallogr2007https://conductscience.org/library/papers/19461840PubMed
723086475Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.Nat Med2012https://conductscience.org/library/papers/23086475PubMed
829162799Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.Nat Commun2017https://conductscience.org/library/papers/29162799PubMed
935963275
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults.
Lancet Infect Dis2022https://conductscience.org/library/papers/35963275PubMed
1032075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
1128807998Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28807998PubMed
1229422648Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.Nat Commun2018https://conductscience.org/library/papers/29422648PubMed
1334368623Improved protein structure prediction by deep learning irrespective of co-evolution information.Nat Mach Intell2021https://conductscience.org/library/papers/34368623PubMed
1432566259Malaria vaccines since 2000: progress, priorities, products.NPJ Vaccines2020https://conductscience.org/library/papers/32566259PubMed
1535812379Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine Candidates.Front Immunol2022https://conductscience.org/library/papers/35812379PubMed
1632079680Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab.Science2020https://conductscience.org/library/papers/32079680PubMed
1733964223Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.Lancet2021https://conductscience.org/library/papers/33964223PubMed
1826488565Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.N Engl J Med2015https://conductscience.org/library/papers/26488565PubMed
1928539451Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers.J Virol2017https://conductscience.org/library/papers/28539451PubMed
202668861Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes.Parasitology1989https://conductscience.org/library/papers/2668861PubMed

See all 76 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42722653The transmission-blocking dynamics of Plasmodium falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adults.Nat Commun2026https://conductscience.org/library/papers/42722653PubMed
42226229Genetic diversity of the Plasmodium falciparum Pfs230 gene in four East African countries supports its potential as a malaria transmission‑blocking vaccine candidate.Malar J2026https://conductscience.org/library/papers/42226229PubMed
41727579The kinetics and transmission-blocking dynamics of P. falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adults.Res Sq2026https://conductscience.org/library/papers/41727579PubMed
41580424A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity.Nat Commun2026https://conductscience.org/library/papers/41580424PubMed
41267740Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.Wellcome Open Res2025https://conductscience.org/library/papers/41267740PubMed
41202138Pfs230 domain 12 is a potent malaria transmission-blocking vaccine candidate.Sci Adv2025https://conductscience.org/library/papers/41202138PubMed
41172338Pfs230 Domains 7-10 Encoded by DNA Vaccines Induce Potent Complement-Independent Transmission-Blocking Antibody Against Plasmodium falciparum.J Infect Dis2026https://conductscience.org/library/papers/41172338PubMed
40033373Antibody correlates of risk of clinical malaria in an area of low and unstable malaria transmission in western Kenya.Malar J2025https://conductscience.org/library/papers/40033373PubMed
39907429Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.Immunol Rev2025https://conductscience.org/library/papers/39907429PubMed
39817720Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.Elife2025https://conductscience.org/library/papers/39817720PubMed
39555079ProC6C, a novel multi-stage malaria vaccine, elicits functional antibodies against the minor and central repeats of the Circumsporozoite Protein in human adults.Front Immunol2024https://conductscience.org/library/papers/39555079PubMed
39209843Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria.Nat Commun2024https://conductscience.org/library/papers/39209843PubMed
39018754Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.EBioMedicine2024https://conductscience.org/library/papers/39018754PubMed
38988315Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes.Protein Sci2024https://conductscience.org/library/papers/38988315PubMed
38793797A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity.Vaccines (Basel)2024https://conductscience.org/library/papers/38793797PubMed
38656211Vaccines and monoclonal antibodies: new tools for malaria control.Clin Microbiol Rev2024https://conductscience.org/library/papers/38656211PubMed
38086855Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody.NPJ Vaccines2023https://conductscience.org/library/papers/38086855PubMed
37542029A human antibody epitope map of the malaria vaccine antigen Pfs25.NPJ Vaccines2023https://conductscience.org/library/papers/37542029PubMed
37481347Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein.Trends Parasitol2023https://conductscience.org/library/papers/37481347PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36792575

GET https://conductscience.org/api/papers/v1/36792575/authors?page=2